Latanoprost.
2 Inquiries
130209-82-4
Shanghai
1g/bag
Yes
2025-04-14
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLatanoprost is an agonist for the FP prostanoid receptor, and lowers intraocular-pressure (IOP).
Liquid
Latanoprost is a prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension. It has a role as an antiglaucoma drug, an antihypertensive agent, an EC 4.2.1.1 (carbonic anhydrase) inhibitor and a prodrug. It is a prostaglandins Falpha, a triol and an isopropyl ester. It derives from a latanoprost free acid.|Latanoprost is a prodrug analog of prostaglandin F2 alpha that is used to treat elevated intraocular pressure (IOP). It was initially approved by the FDA in 1998. Latanoprost is the first topical prostaglandin F2 alpha analog used for glaucoma treatment. It has been found to be well-tolerated and its use does not normally result in systemic adverse effects like other drugs used to treat elevated intraocular pressure, such as [Timolol]. Another benefit latanoprost is that it can be administered once a day.|Latanoprost is a Prostaglandin Analog.|Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.|A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.Basic Info-
Product Name:
Latanoprost
Other Name:5-Heptenoic acid,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-,1-methylethyl ester,(5Z)-;5-Heptenoic acid,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-,1-methylethyl ester,[1R-[1α(Z),2β(R*),3α,5α]]-;Latanoprost;PhXA 41;XA 41;Xalatan;GAAP Ofteno;(15R)-Latanoprost;Prolatan;(+)-Latanoprost;474944-24-6;144489-49-6
CAS No.:130209-82-4
Molecular Formula:C26H40O5
InChIKeys:InChIKey=GGXICVAJURFBLW-CEYXHVGTSA-N
Molecular Weight:432.59
Exact Mass:432.59
EC Number:1806241-263-5
UNII:6Z5B6HVF6O
DSSTox ID:DTXSID1041057
NCI Thesaurus Code:C29151
ATC Code:S01EE|S - Sensory organs
HScode:2937500000
Categories:
Characteristics-
PSA:
87
XLogP3:3.98
Appearance:pale yellow oil
Density:1.1±0.1 g/cm3
Boiling Point:583.8°C at 760 mmHg
Flash Point:188.3±23.6 °C
Refractive Index:1.538
Water Solubility:DMSO: freely soluble
Storage Conditions:−20°C
Specific rotation:D20 +31.57° (c = 0.91 in acetonitrile)
PKA:4.88None
Dissociation Constants:4.88
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 1, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H300 Fatal if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
Italy
Latanoprost
1 G Feb 2, 2025 
United States
Latanoprost
500 MG Jul 7, 2026 Post an enquiry for this product
